Merck & Co Inc (MRK)
98.05
-1.47
(-1.48%)
USD |
NYSE |
Dec 20, 16:00
98.88
+0.83
(+0.85%)
After-Hours: 20:00
Merck Free Cash Flow: 14.84B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.291B |
| Cash from Investing (Quarterly) | -3.845B |
| Cash from Financing (Quarterly) | -2.425B |
| Free Cash Flow Per Share (Quarterly) | 3.348 |
| Free Cash Flow to Equity (Quarterly) | 8.165B |
| Free Cash Flow to Firm (Quarterly) | 8.665B |
| Free Cash Flow Yield | 5.95% |